Jan 12 (Reuters) - The European medicines regulator said on Tuesday it had received an application from AstraZeneca for the conditional approval of its COVID-19 vaccine being developed along with the University of Oxford. (Reporting by Pushkala Aripaka in Bengaluru; Editing by Saumyadeb Chakrabarty)
我们的标准: 汤森路透“信任原则”